Showing 7841-7850 of 8355 results for "".
- BioPharmX Completes Phase 2b Trial of BPX-01; Topline Results Coming Soonhttps://practicaldermatology.com/news/biopharmx-completes-phase-2b-trial-of-bpx-01-topline-results-coming-soon/2458217/BioPharmX Corporation completed their last subject visit in a Phase 2b trial of their investigational acne drug, BPX-01, and the last site close-out visit was April 7, 2017. The company now plans to announce topline data from the trial in the fi
- New “Sonoillumination” Waveguide Device Set to Improve Laser Surgeryhttps://practicaldermatology.com/news/new-sonoillumination-waveguide-device-set-to-improve-laser-surgery/2458221/One of the biggest issues with the lasers used to treat benign vascular birthmarks, port-wine stains and for tattoo removal is making sure the laser light, which is held at a distance from the skin, is perfectly and selectively absorbed by only the targeted birthmark or tattoo. Paul J.D.
- Novan: Positive Topline Results with Fungicidal SB208 in Phase 2 Trialhttps://practicaldermatology.com/news/nolan-positive-topline-results-with-fungicidal-sb208-in-phase-2-trial/2458222/Novan, Inc. has announced positive topline results from their Phase 2 clinical trial with SB208, a topical, silicone based-gel under development for the treatment of infections caused by dermatophytes such as Trichophyton rubrum, or T. rubrum. Novan’s SB208 Gel, at bo
- Maria Carell Named New CEO of Revision Skincare LLC, Goodier Cosmetics LLChttps://practicaldermatology.com/news/maria-carell-named-new-ceo-of-revision-skincare-llc-goodier-cosmetics-llc/2458223/Maria Carell is the new CEO of Revision Skincare® LLC and Goodier Cosmetics LLC. Ms. Carell's appointment follows the retirement of John Muller, the company's founder. Mr. Muller will retain hi
- Phase 4 Studies of Restylane® Refyne and Restylane® Defyne Show Lasting Natural Benefithttps://practicaldermatology.com/news/phase-4-studies-of-restylane-refyne-and-restylane-defyne-show-lasting-natural-benefit/2458226/Two Phase 4 clinical studies of Restylane® Refyne and Restylane® Defyne show that the natural-looking results last. Specifically, the Natural Expression study found that naturalness in facial expressions was at least main
- Study: Severe Psoriasis More Common in Menhttps://practicaldermatology.com/news/severe-psoriasis-more-common-in-men/2458235/Severe psoriasis predominantly affects men, according to a new study in the American Journal of Clinical Dermatology. In the study of 5,438 Swedish psoriasis patients, women had significantly (p<0.
- Topix Pharmaceuticals Rolls Out Replenix RetinolForte Treatment Serumhttps://practicaldermatology.com/news/topix-pharmaceuticals-rolls-out-replenix-retinolforte-treatment-serum/2458242/Topix Pharmaceuticals is adding Replenix® RetinolForte Treatment Serum to their portfolio of offerings. The serum’s patent-pending, time-released Micropolymer delivery system deposits retinol into t
- Survey Findings: Submental Region Major Pain Point for Patientshttps://practicaldermatology.com/news/survey-findings-submental-region-major-pain-point-for-patients/2458247/Close to 50 percent of individuals are bothered by the appearance of the area under their chin, and many alter their behavior as a result, according to a new survey commissioned by
- Sunburn Risk May Be Greatest in Skin of Colorhttps://practicaldermatology.com/news/sunburn-risk-may-be-greatest-in-skin-of-color/2458271/Sunburn risk is greatest for young adults with melanin-rich skin, according to a study published in The Journal of the American Osteopathic Association. Researchers found a surprising correlation between reporting a red
- Obagi Medical Products Collaborates with Suzan Obagi, MD and Nextcell Medical to Introduce New Linehttps://practicaldermatology.com/news/obagi-medical-products-collaborates-with-suzan-obagi-md-and-nextcell-medical-to-introduce-new-line/2458274/Valeant Pharmaceuticals International, Inc.’s wholly owned subsidiary Obagi Medical Products collaborated with Nextcell Medical Company to claim exclusive distribution of Suzan Obagi, MD’s line of skin care products throughout the United States. Established in 2013 with cosmetic